The post Is XRP the Modern Answer to SDR Limitations? Crypto Market Starts Talkin appeared first on Coinpedia Fintech News Apex Crypto executive Jesse has sharedThe post Is XRP the Modern Answer to SDR Limitations? Crypto Market Starts Talkin appeared first on Coinpedia Fintech News Apex Crypto executive Jesse has shared

Is XRP the Modern Answer to SDR Limitations? Crypto Market Starts Talkin

2026/02/17 22:51
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
XRP Price

The post Is XRP the Modern Answer to SDR Limitations? Crypto Market Starts Talkin appeared first on Coinpedia Fintech News

Apex Crypto executive Jesse has shared a fresh view about the long-term purpose of XRP. According to him, the digital asset may have been part of a much longer financial transition tied to global liquidity systems, a theory that is already fueling strong reactions across the industry.

Jesse stated, “XRP has been planned for many, many years,” arguing that earlier global reserve experiments struggled because they were not widely accessible across the financial system. His comments centered on the historical evolution of global reserve structures and why earlier models failed to achieve universal adoption.

The Historical Context Behind the Claim

Following World War II, global policymakers debated whether to adopt the U.S. dollar as the main reserve currency or create a neutral international settlement unit. The dollar ultimately became the global reserve standard, but economists warned that relying on a sovereign currency to supply global liquidity could create long-term structural challenges.

In 1968, the International Monetary Fund introduced Special Drawing Rights, known as SDRs, to support global liquidity and trade. However, SDR adoption remained limited. Jesse explained, “They only gave it to central banks. They did not give it to commercial banks, fintechs, corporations, and individuals,” arguing that this restricted access prevented the system from reaching the global liquidity scale policymakers expected.

Why XRP Is Being Pulled Into the Discussion

Jesse says modern blockchain settlement networks could address those earlier adoption barriers. He pointed out that digital asset payment rails allow multiple participants across the financial system to interact simultaneously, potentially improving global settlement efficiency. According to him, “This is why the SDR never got the global adoption they were hoping for,” suggesting that broader accessibility could be a defining advantage of blockchain-based liquidity systems.

The argument is controversial because it touches on the possibility that blockchain settlement layers could eventually complement or reshape existing cross-border payment infrastructure. Supporters of the idea highlight the growing experimentation by financial institutions with faster settlement systems, while critics caution that global monetary structures evolve slowly and require deep regulatory coordination.

For now, XRP remains primarily associated with cross-border settlement experimentation, yet the resurfacing of long-term global liquidity narratives shows that the debate around its potential role is far from settled.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09